Innate Pharma S.A. Banner Image

Innate Pharma S.A.

  • Ticker IPHA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Innate Pharma S.A. Logo Image
  • 201-500 Employees
  • Based in Marseille, France
Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s commercial-stage product, Lumoxiti, in-licensed from AstraZeneca, was approved by the FDA in September 2018. Lumoxiti is a first-in class specialty oncologyMore product for hairy cell leukemia (HCL). Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.
Innate Pharma S.A.

Most Recent Annual Report

Innate Pharma S.A.
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports